Immune response to revaccination with meningococcal A and C polysaccharides in Gambian children following repeated immunisation during early childhood.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Vaccine

• Publication date

  1999-08-06

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0264-410X(99)00139-5PMID 10462244
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Age-Dependent Neisseria meningitidis Serogroup C Class-Specific Antibody Concentrations and Bactericidal Titers in Sera from Young Children from Montana Immunized with a Licensed Polysaccharide Vaccine

  1998cited by this paper
• Standardization and a multilaboratory comparison of Neisseria meningitidis serogroup A and C serum bactericidal assays. The Multilaboratory Study Group

  1997cited by this paper
• Induction of immunologic memory in Gambian children by vaccination in infancy with a group A plus group C meningococcal polysaccharide-protein conjugate vaccine.

  1997cited by this paper
• "Love's labours lost": failure to implement mass vaccination against group A meningococcal meningitis in sub-Saharan Africa.

  1997cited by this paper
• Circulating antibody secreting cells and humoral antibody response after parenteral immunization with a meningococcal polysaccharide vaccine.

  1996cited by this paper
• Conjugate meningococcal serogroup A and C vaccine: reactogenicity and immunogenicity in United Kingdom infants.

  1996cited by this paper
• Assignment of Neisseria meningitidis serogroup A and C class-specific anticapsular antibody concentrations to the new standard reference serum CDC1992

  1995cited by this paper
• A trial of a group A plus group C meningococcal polysaccharide-protein conjugate vaccine in African infants.

  1995cited by this paper
• Multicenter comparison of Neisseria meningitidis serogroup C anti-capsular polysaccharide antibody levels measured by a standardized enzyme-linked immunosorbent assay

  1994cited by this paper
• Multicenter comparison of levels of antibody to the Neisseria meningitidis group A capsular polysaccharide measured by using an enzyme-linked immunosorbent assay

  1992cited by this paper
• Epidemic group C meningococcal meningitis in Upper Volta, 1979.

  1983cited by this paper
• Serum antibodies to capsular polysaccharide vaccine of group A Neissera meningitidis followed for three years in infants and children.

  1980cited by this paper
• Kinetics of antibody production to group A and group C meningococcal polysaccharide vaccines administered during the first six years of life: prospects for routine immunization of infants and children.

  1979cited by this paper
• Immune Response of human infants of polysaccharide vaccines of group A and C Neisseria meningitidis.

  1977cited by this paper
• Comparative study of group A and group C meningococcal infection.

  1977cited by this paper
• Clinical evaluation of group A and group C meningococcal polysaccharide vaccines in infants.

  1975cited by this paper
• Response of children to Neisseria meningitidis polysaccharide vaccines.

  1973cited by this paper
• HUMAN IMMUNITY TO THE MENINGOCOCCUS

  1969cited by this paper

• Cost-effectiveness analysis of vaccination strategies against meningococcal disease for children under nine years of age in China

  2024cites this paper
• Comparison of Immune Responses to Two Quadrivalent Meningococcal Conjugate Vaccines (CRM197 and Diphtheria Toxoid) in Healthy Adults

  2019cites this paper
• Effect of A Sun Protection Intervention on the Immune Response to Measles Booster Vaccination in Infants in Rural South Africa

  2018influential citation
• Immunogenicity of meningococcal polysaccharide ACWY vaccine in primary immunized or revaccinated adults

  2018cites this paper
• Progress toward the global control of Neisseria meningitidis: 21st century vaccines, current guidelines, and challenges for future vaccine development

  2018cites this paper
• 125 – Neisseria meningitidis

  2018cites this paper
• Early detection and response to meningococcal disease epidemics in sub-SaharanAfrica : appraisal of theWHOstrategy

  2017cites this paper
• A Seroepidemiological Study of Serogroup A Meningococcal Infection in the African Meningitis Belt

  2016cites this paper
• 10 – Complement Deficiencies

  2016cites this paper
• Prevalence of meningococcal meningitis in China from 2005 to 2010.

  2015cites this paper
• Neisseria meningitidis Group A IgG1 and IgG2 Subclass Immune Response in African Children Aged 12–23 Months Following Meningococcal Vaccination

  2015cites this paper
• Serogroup A meningococcal conjugate vaccines in Africa

  2015cites this paper
• Prevention and Control of Meningococcal Disease

  2014cites this paper
• Synthesis of fragments of the capsular polysaccharide of Neisseria meningitidis (serogroup A) suitable for bioconjugation

  2014cites this paper
• Vaccines for low-income countries.

  2013cites this paper
• 21 – Meningococcal vaccines

  2013cites this paper
• Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP).

  2013cites this paper
• Meningococcal disease and the complement system

  2013cites this paper
• Single validation of CE method for determining free polysaccharide content in a Brazilian meningococcal C conjugate vaccine

  2013cites this paper
• Glycoconjugate vaccines

  2013cites this paper
• Use and interpretation of diagnostic vaccination in primary immunodeficiency: a working group report of the Basic and Clinical Immunology Interest Section of the American Academy of Allergy, Asthma & Immunology.

  2012cites this paper
• Immune suppression induced by Vi capsular polysaccharide is overcome by Vi-DT conjugate vaccine.

  2012cites this paper
• Hyporesponsiveness following booster immunization with bacterial polysaccharides is caused by apoptosis of memory B cells.

  2012cites this paper
• Review of the cost effectiveness of immunisation strategies for the control of epidemic meningococcal meningitis

  2012cites this paper
• Morbidity and Mortality Weekly Report

  2012cites this paper
• WITHDRAWN: Conjugate vaccines for preventing meningococcal C meningitis and septicaemia.

  2011cites this paper
• Extra-Immunization as a Clinical Indicator for Fragmentation of Care

  2011cites this paper
• Conjugate vaccines for preventing meningococcal C meningitis and septicaemia.

  2011cites this paper
• Mother-infant antibodies to pneumococcal polysaccharides and proteins : Transfer and persistence of maternal antibodies and development of vaccine-induced and naturally acquired antibodies in infants

  2011cites this paper
• Mother-infant vaccination with pneumococcal polysaccharide vaccine: persistence of maternal antibodies and responses of infants to vaccination.

  2011cites this paper
• Concomitant Administration of Mycobacterium bovis BCG with the Meningococcal C Conjugate Vaccine to Neonatal Mice Enhances Antibody Response and Protective Efficacy

  2011cites this paper
• Separação e quantificação de proteína e polissacarídeo livres na vacina meningocócica C conjugada brasileira utilizando eletroforese capilar

  2011cites this paper
• Dose-ranging study of a single injection of pneumococcal conjugate vaccine (1 ×, 2 ×, or 4 ×) in healthy subjects aged 70 years or older.

  2011cites this paper
• Quadrivalent meningococcal vaccines: hyporesponsiveness as an important consideration when choosing between the use of conjugate vaccine or polysaccharide vaccine.

  2010cites this paper
• Infections of People with Complement Deficiencies and Patients Who Have Undergone Splenectomy

  2010cites this paper
• Prospects and challenges with introduction of a mono-valent meningococcal conjugate vaccine in Africa.

  2009cites this paper
• Quadrivalent meningococcal ACYW-135 glycoconjugate vaccine for broader protection from infancy

  2009cites this paper
• Global review of meningococcal disease. A shifting etiology

  2009cites this paper
• Epidemic meningitis due to Group A Neisseria meningitidis in the African meningitis belt: a persistent problem with an imminent solution.

  2009cites this paper
• Demonstration of Immunologic Memory Using Serogroup C Meningococcal Glycoconjugate Vaccine

  2009cites this paper
• Meningococcal disease in international travel: vaccine strategies.

  2008cites this paper
• Vaccine-preventable diseases in long-term expatriates.

  2008cites this paper
• Persistence of protection against invasive bacteria : memory B cell responses in infants after immunisation

  2008cites this paper
• Cochrane review: Conjugate vaccines for preventing meningococcal C meningitis and septicaemia

  2007cites this paper
• Reconsideration of the Use of Meningococcal Polysaccharide Vaccine

  2007cites this paper
• Combined schedules of pneumococcal conjugate and polysaccharide vaccines: is hyporesponsiveness an issue?

  2007cites this paper
• Meningococcal A, C, Y and W-135 polysaccharide-protein conjugate vaccines

  2007cites this paper
• An evaluation of the immunogenicity and safety of a new trivalent meningococcal polysaccharide vaccine.

  2007cites this paper
• Meningococcal and Pneumococcal Meningitis in Northern Ghana

  2007cites this paper
• Meningococcal vaccines : past , present , and future perspectives

  2007cites this paper
• Use of Meningococcal Vaccines in the United States

  2007cites this paper
• Immunologic memory response induced by a meningococcal serogroup C conjugate vaccine using the P64k recombinant protein as carrier.

  2006cites this paper
• Priming for Immunologic Memory in Adults by Meningococcal Group C Conjugate Vaccination

  2006cites this paper
• Comparison of three ELISA protocols to measure antibody responses elicited against serogroup C meningococcal polysaccharide in mouse, monkey and human sera.

  2006cites this paper
• The new meningococcal conjugate vaccine

  2006cites this paper
• Experience with MCV-4, a meningococcal, diphtheria toxoid conjugate vaccine against serogroups A, C, Y and W-135

  2006cites this paper
• Anti-pneumococcal antibody titre measurement: what useful information does it yield?

  2006cites this paper
• Clinical practice. Prevention of meningococcal disease.

  2006cites this paper
• Immunisation handbook 2006

  2006cites this paper
• Prevention of Meningococcal Disease

  2006cites this paper
• Canada Communicable Disease Report Relevé des maladies transmissibles au Canada

  2006cites this paper
• Persistence of Group C Anticapsular Antibodies Two to Three Years After Immunization With an Investigational Quadrivalent Neisseria meningitidis-Diphtheria Toxoid Conjugate Vaccine

  2005cites this paper
• Meningococcal conjugate vaccines

  2005cites this paper
• Meningococcal Conjugate Vaccine in Adolescents and Children

  2005cites this paper
• Immunologic Hyporesponsiveness to Serogroup C but Not Serogroup A following Repeated Meningococcal A/C Polysaccharide Vaccination in Saudi Arabia

  2004influential citation
• Opportunities for control of meningococcal disease in the United States.

  2004cites this paper
• Serologic correlates of protection for evaluating the response to meningococcal vaccines

  2004cites this paper
• Meningococcal Vaccines

  2004cites this paper
• Morbidity and Mortality Weekly Report

  2004cites this paper
• Evaluation of serogroup A meningococcal vaccines in Africa: a demonstration project.

  2004cites this paper
• Immunogenicity and efficacy of childhood vaccines in HIV-1-infected children.

  2004cites this paper
• Routine Vaccination with Polysaccharide Meningococcal Vaccines Is an Ineffective and Possibly Harmful Strategy

  2003cites this paper
• Immunogenicity and immunological priming of the serogroup a portion of a bivalent meningococcal A/C conjugate vaccine in 2-year-old children.

  2003cites this paper
• Critical analysis of old and new vaccines against N. meningitidis serogroup C, considering the meningococcal disease epidemiology in Brazil.

  2003cites this paper
• Meningococcal disease and travel

  2003cites this paper
• Neisseria meningitidis serogroup A vaccines: an overview

  2003cites this paper
• Meningococcal disease and travel.

  2003cites this paper
• Meningococcal meningitis in sub-Saharan Africa: the case for mass and routine vaccination with available polysaccharide vaccines.

  2003cites this paper
• Resposta Imune a uma vacina protéica antimeningocócica B : estudo da influência de intervalos de tempo entre as imunizações

  2003cites this paper
• A Glycoconjugate Vaccine for Neisseria meningitidis Induces Antibodies in Human Infants That Afford Protection against Meningococcal Bacteremia in a Neonate Rat Challenge Model

  2002cites this paper
• Anticapsular polysaccharide meningococcal antibodies in Israeli military recruits: immune status and the effect of simultaneous administration of immune globulin on the response to polysaccharide vaccine.

  2002cites this paper
• Epidemic meningococcal disease and travel.

  2002cites this paper
• Mucosal immune responses to meningococcal conjugate polysaccharide vaccines in infants

  2002cites this paper
• Meningococcal serogroup C conjugate vaccine

  2002cites this paper
• Meningococcal disease: treatment and prevention

  2002cites this paper
• Early detection and response to meningococcal disease epidemics in sub-Saharan Africa: appraisal of the WHO strategy.

  2002cites this paper
• Vaccines for the prevention of meningococcal disease in children.

  2002cites this paper
• Safety and immunogenicity of meningococcus serogroup C conjugate vaccine administered as a primary or booster vaccination to healthy four-year-old children

  2002cites this paper
• Evaluation of diagnostic tests for influenza in a pediatric practice

  2002cites this paper
• Meningococcal vaccines

  2002cites this paper
• Meningococcal disease and travel.

  2002cites this paper
• Oesophageal varix bleed

  2001cites this paper
• Immunologic memory 5 years after meningococcal A/C conjugate vaccination in infancy.

  2001cites this paper
• Immune response and host-pathogen interactions.

  2001cites this paper
• Primary and Booster Mucosal Immune Responses to Meningococcal Group A and C Conjugate and Polysaccharide Vaccines Administered to University Students in the United Kingdom

  2001cites this paper
• Effect of pre-existing immunity for systemic and mucosal immune responses to intranasal immunization with group B Streptococcus type III capsular polysaccharide-cholera toxin B subunit conjugate.

  2001cites this paper
• Epidemiology of meningococcal disease in north america.

  2001cites this paper
• Clinical implications of the specialised B cell response to polysaccharide encapsulated pathogens

  2001cites this paper
• Meningococcal disease and vaccination in North America

  2001cites this paper
• Pneumococcal disease in Australia: the immunological basis of pneumococcal vaccines

  2001cites this paper